Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone

Keystone, Edward; C. Breedveld, Ferdinand; van der Heijde, Désirée; van Vollenhoven, Ronald; Emery, Paul; S Smolen, Josef; Sainsbury, Iain; Florentinus, S.; Küpper, H.; Chen, Kun; Kavanaugh, Arthur

doi:10.1136/rmdopen-2017-000445

Public

Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone

Published in RMD Open • Sep 1, 2017

Authors:

Edward Keystone

Ferdinand C. Breedveld

Désirée van der Heijde

Abstract

OBJECTIVE: To evaluate the achievement of comprehensive disease control (CDC) following 1 year of treatment with adalimumab+methotrexate versus methotrexate alone and whether early achievement of remission (at week 24 or 26) is associated with CDC at week 52 in patients with either early or establis...

Subject

Adalimumab

Methotrexate

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!